Hyliion holder plans sale of 15,000 shares
Hyliion Holdings Corp. (HYLN) is the issuer for a planned resale of its common stock under Rule 144.
Rhea-AI Filing Summary
Hyliion Holdings Corp. (HYLN) is the issuer for a planned resale of its common stock under Rule 144. UBS Financial Services Inc., as broker, has filed on behalf of Jose Oxholm for the potential sale of up to 15,000 shares of Hyliion common stock on the NYSE around 08/21/2026. The notice also reports that 30,000 shares of common stock were acquired for cash on 08/20/2026 in connection with an employee benefit arrangement.
Positive
- None.
Negative
- None.
Key Figures
Shares proposed to be sold: 15,000 shares of common stock
Shares acquired under employee benefit: 30,000 shares of common stock
Shares outstanding: 178,600,000 shares of common stock
+1 more
4 metrics
Shares proposed to be sold
15,000 shares of common stock
Planned Rule 144 sale through UBS Financial Services Inc. around 08/21/2026
Shares acquired under employee benefit
30,000 shares of common stock
Acquired for cash on 08/20/2026 in connection with Employee Benefit
Shares outstanding
178,600,000 shares of common stock
Number of Hyliion common shares outstanding as reported in the notice
Planned sale date
08/21/2026
Approximate date of proposed Rule 144 sale on the NYSE
Key Terms
Rule 144, attorney-in-fact, Employee Benefit
3 terms
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
attorney-in-fact regulatory
"for UBS Financial Services Inc, as attorney-in-fact for Jose Oxholm"
An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.
Employee Benefit financial
"Common Stock | 08/20/2026 | Employee Benefit | Hyliion Holdings Corp"
FAQ
What does the Form 144 filing disclose for HYLN?
It discloses that Jose Oxholm, through UBS Financial Services Inc., has filed to potentially sell up to 15,000 shares of Hyliion Holdings Corp. common stock under Rule 144, with sales expected around 08/21/2026 on the NYSE.
Who is the selling security holder in this Hyliion (HYLN) Form 144?
The selling security holder is Jose Oxholm. The Form 144 is signed by Joseph Cassidy for UBS Financial Services Inc., acting as attorney-in-fact for Jose Oxholm, in connection with a planned Rule 144 sale of Hyliion common stock.
AI-generated analysis. How Rhea-AI works. Not financial advice.